Legis Daily

Matt’s Act

USA117th CongressHR-4813| House 
| Updated: 7/30/2021
Jeff Fortenberry

Jeff Fortenberry

Republican Representative

Nebraska

Cosponsors (1)
Angie Craig (Democratic)

Health Subcommittee, Energy and Commerce Committee, Education and Workforce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Matt's Act This bill limits the amount that private health insurance plans may charge plan holders for insulin drugs to a maximum of $20, or $0 for high deductible plans; pharmacies may charge uninsured individuals the average price of such drugs after deducting any rebates and discounts provided by drug manufacturers, plus limited additional charges for distributing and dispensing costs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-7722
Matt’s Act
Jul 29, 2021
Introduced in House
Jul 29, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 30, 2021
Referred to the Subcommittee on Health.

  • Bill from Previous Congress

    HR 116-7722
    Matt’s Act
  • July 29, 2021
    Introduced in House
  • July 29, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • July 30, 2021
    Referred to the Subcommittee on Health.

Health

Matt’s Act

USA117th CongressHR-4813| House 
| Updated: 7/30/2021
Matt's Act This bill limits the amount that private health insurance plans may charge plan holders for insulin drugs to a maximum of $20, or $0 for high deductible plans; pharmacies may charge uninsured individuals the average price of such drugs after deducting any rebates and discounts provided by drug manufacturers, plus limited additional charges for distributing and dispensing costs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-7722
Matt’s Act
Jul 29, 2021
Introduced in House
Jul 29, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 30, 2021
Referred to the Subcommittee on Health.

  • Bill from Previous Congress

    HR 116-7722
    Matt’s Act
  • July 29, 2021
    Introduced in House
  • July 29, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • July 30, 2021
    Referred to the Subcommittee on Health.
Jeff Fortenberry

Jeff Fortenberry

Republican Representative

Nebraska

Cosponsors (1)
Angie Craig (Democratic)

Health Subcommittee, Energy and Commerce Committee, Education and Workforce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted